Identification of Myotubularin As the Lipid Phosphatase Catalytic Subunit Associated with the 3-Phosphatase Adapter Protein, 3-PAP

Total Page:16

File Type:pdf, Size:1020Kb

Identification of Myotubularin As the Lipid Phosphatase Catalytic Subunit Associated with the 3-Phosphatase Adapter Protein, 3-PAP Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP Harshal H. Nandurkar*†, Meredith Layton‡, Jocelyn Laporte§, Carly Selan*, Lisa Corcoran*¶, Kevin K. Caldwellʈ, Yasuhiro Mochizuki**, Philip W. Majerus**, and Christina A. Mitchell¶ *St. Vincent’s Hospital, 3065 Melbourne, Australia; ‡Ludwig Institute of Medical Research, 3050 Parkville, Australia; §Institute of Genetics and Molecular and Cellular Biology, 67404 Illkirch Cedex, France; ¶Department of Biochemistry and Molecular Biology, Monash University, 3068 Clayton, Australia; ʈDepartment of Neuroscience, University of New Mexico, Albuquerque, NM 87131; and **Department of Haematology, Washington University Medical School, St. Louis, MO 63110 Contributed by Philip W. Majerus, May 21, 2003 Myotubularin is a dual-specific phosphatase that dephosphory- syndrome, a hereditary demyelinating peripheral neuropathy lates phosphatidylinositol 3-phosphate and phosphatidylinositol (17, 18). (3,5)-bisphosphate. Mutations in myotubularin result in the human The catalytically inactive myotubularin family members in- disease X-linked myotubular myopathy, characterized by persis- clude SET-binding factor 1 (MTMR5), LIP-STYX (MTMR9), tence of muscle fibers that retain an immature phenotype. We have MTMR10, the 3-phosphatase adapter protein (3-PAP) previously reported the identification of the 3-phosphatase (MTMR12), and MTMR13 (SET-binding factor 2) (7, 14–16, 19, adapter protein (3-PAP), a catalytically inactive member of the 20). The function of these catalytically inactive phosphatases is myotubularin gene family, which coprecipitates lipid phosphati- unknown. Very recently, mutations in MTMR13 have been dylinositol 3-phosphate-3-phosphatase activity from lysates of described in type 4B2 Charcot Marie Tooth syndrome (19, 20). human platelets. We have now identified myotubularin as the Also, male mice deficient in SET-binding factor 1 are azoosper- catalytically active 3-phosphatase subunit interacting with 3-PAP. matic and infertile (21). We originally purified 3-PAP from rat A 65-kDa polypeptide, coprecipitating with endogenous 3-PAP, brain as a heterodimer with an unidentified 65-kDa PtdIns(3)P was purified from SDS͞PAGE, subjected to trypsin digestion, and 3-phosphatase (22). The human 3-PAP cDNA had sequence and analyzed by collision-induced dissociation tandem MS. Three pep- domain homology with myotubularin, but lacked the HCX5R tides derived from human myotubularin were identified. Associa- catalytic motif (23). Recombinant 3-PAP did not dephosphor- tion between 3-PAP and myotubularin was confirmed by reciprocal ylate PtdIns(3)P; however, 3-PAP immunoprecipitates from coimmunoprecipitation of both endogenous and recombinant pro- human platelet cytosol exhibited PtdIns(3)P 3-phosphatase ac- teins expressed in K562 cells. Recombinant myotubularin localized tivity, suggesting 3-PAP functions as an adapter subunit to an to the plasma membrane, causing extensive filopodia formation. unidentified PtdIns(3)P 3-phosphatase (23). In this study we have identified myotubularin as a catalytic However, coexpression of 3-PAP with myotubularin led to atten- subunit that complexes with 3-PAP. Furthermore, 3-PAP de- uation of the plasma membrane phenotype, associated with myo- termines myotubularin cytosolic localization, and thereby alters tubularin relocalization to the cytosol. Collectively these studies the phenotype of myotubularin-overexpressing cells. indicate 3-PAP functions as an ‘‘adapter’’ for myotubularin, regu- lating myotubularin intracellular location and thereby altering the Materials and Methods phenotype resulting from myotubularin overexpression. Materials. Restriction and DNA-modifying enzymes were ob- tained from Promega. Antibodies against myotubularin have hosphoinositide 3-kinase-derived molecules regulate diverse been described (24). Antibody to the FLAG epitope (mAb Psignaling functions including vesicular trafficking, actin cy- KM5–1C7) was obtained from the Walter and Eliza Hall Insti- toskeletal rearrangement, apoptosis, and cell proliferation (1, 2). tute of Medical Research (Melbourne). mAb to the hemagglu- The signaling molecule phosphatidylinositol 3-phosphate tinin (HA) epitope used to probe immunoblots was obtained [PtdIns(3)P] binds and localizes FYVE, Phox, and pleckstrin from Silenus (Novi, MI). Polyclonal antibody to the HA epitope homology domain-containing proteins to specific subcellular used in microscopy was obtained from Upstate Biotechnology compartments such as early and late endosomes and thereby (Lake Placid, NY). All fluorochrome-tagged secondary anti- regulates endosomal and other vesicular trafficking pathways bodies (Alexa Fluor) were supplied by Molecular Probes, and (3–5). horseradish peroxidase-tagged secondary antibodies for immu- Myotubularin is a dual-specificity protein tyrosine phos- noblot analysis were obtained from DAKO. The pCGN vector phatase-like enzyme, which contains a HCX5R catalytic motif was a gift from Tony Tiganis (Monash University), pEFBOS- and functions as a PtdIns(3)P and phosphatidylinositol 3,5- FLAG vector was a gift from Tracey Willson (Walter and Eliza bisphosphate [PtdIns(3,5)P2] 3-phosphatase (6–11, 12). The Hall Institute of Medical Research), and the myotubularin and myotubularin gene locus, MTM1, is mutated in X-linked myo- MTMR2 cDNA were from G. S. Taylor (University of Michigan tubular myopathy, a severe congenital disorder characterized by Medical School, Ann Arbor). All other reagents were from neonatal generalized muscle weakness, hypotonia, and death Sigma-Aldrich unless otherwise stated. early in life (13). Myotubularin defines the largest family of lipid phosphatases in the human genome, which includes eight cata- Cloning of MTMR6 cDNA. The MTMR6 cDNA was amplified by lytically active enzymes, and in addition six putative inactive PCR, using the human brain cDNA library (Marathon Ready homologues of unknown function, which contain mutations within the HCX5R catalytic motif (14–16). Mutations in the Abbreviations: PtdIns(3)P, phosphatidylinositol 3-phosphate; PtdIns(3,5)P2, phosphatidyl- myotubularin-related gene MTMR2, which encodes a PtdIns(3)P inositol 3,5-bisphosphate; 3-PAP, 3-phosphatase adapter protein; HA, hemagglutinin; SID, and PtdIns(3,5)P2 3-phosphatase, are responsible for the neu- SET-interacting domain. rodegenerative disorder, type 4B1 Charcot Marie Tooth †To whom correspondence should be addressed. E-mail: [email protected]. 8660–8665 ͉ PNAS ͉ July 22, 2003 ͉ vol. 100 ͉ no. 15 www.pnas.org͞cgi͞doi͞10.1073͞pnas.1033097100 Downloaded by guest on September 23, 2021 troporation and harvested 48 h later. Lysates were prepared, and immunoprecipitation was as described above. Epitope-tagged recombinant proteins were immunoprecipitated with 1–2 ␮gof the appropriate anti-HA or anti-FLAG antibody. All immuno- blots were probed with goat anti-rabbit or goat anti-mouse secondary antibodies conjugated to horseradish peroxidase and detected by enhanced chemiluminescent substrate (Pierce). Recombinant FLAG-tagged MTM1, MTMR2, and HA- tagged MTMR6 were coexpressed with Myc-tagged 3-PAP in COS-7 cells. Myc-tagged 3-PAP was immunoprecipitated with anti-Myc polyclonal antibody and probed by using anti-Flag antibody for MTM1 and MTMR2 and anti-HA antibody for MTMR6. Immunoprecipitates of Myc-3-PAP were also probed with anti-Myc antibody to ensure equal loading of recombinant 3-PAP. Identification of Myotubularin in the Immunoprecipitates of Endog- enous 3-PAP. Immunoprecipitates from 5 ϫ 108 K562 cells (per- formed in batches and pooled), using 250 ␮g of anti-3-PAP antibody and 1,000 ␮l of slurry of protein A-Sepharose in Fig. 1. Immunoprecipitation of 3-PAP and a 65-kDa polypeptide. (A) Mod- ⅐ ͞ ular structure of 3-PAP and 3-PAP⌬SID. The extent of the myotubularin Tris NaCl, were separated by 1D SDS PAGE (7.5% acrylamide) homology region and the SID is shown. The box identified by a star represents and stained with Coomassie blue R250. The polypeptide mi- the mutated catalytic motif. Amino acids 24–40 represent the immunogenic grating at 65 kDa was excised and digested in situ with 0.5 ␮gof peptide used to raise the polyclonal rabbit anti-3-PAP antibody. The amino trypsin (25). Generated peptides were resolved by using capillary acids deleted in 3-PAP⌬SID variant are shown. (B) Proteins were immunopre- reversed-phase HPLC (26) and identified by collision-induced cipitated (IP) from 107 K562 cells, using 5 ␮g of either anti-3-PAP antibody dissociation tandem MS using a quadrupole ion-trap mass (anti-3-PAP) or nonimmune sera (NI), and examined by immunoblot (WB) spectrometer (model LCQ, Finnigan-MAT, San Jose, CA) analysis probed with the anti-3-PAP antibody. The migration of 3-PAP and Ig equipped with electrospray ionization (27). The sequences of heavy chain (Ig) is marked by arrows. MW indicates the migration of molecular mass markers (kDa). (C) Immunoprecipitates prepared as above were pooled uninterpreted collision-induced dissociation spectra were iden- and separated by SDS͞PAGE and visualized by silver stain. The migration of the tified by using the SEQUEST algorithm and confirmed by manual de 65-kDa polypeptide that coimmunoprecipitates with 3-PAP is indicated. novo interpretation of their b- and y-type production series (28). PtdIns(3)P 3-Phosphatase Assays. PtdIns(3)32P was generated as cDNA kit, CLONTECH) as a template and ligated into a described (23). Immunoprecipitates prepared from parental pCMV5-HA expression
Recommended publications
  • The Role of PI3P Phosphatases in the Regulation of Autophagy
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 584 (2010) 1313–1318 journal homepage: www.FEBSLetters.org Review The role of PI3P phosphatases in the regulation of autophagy Isabelle Vergne a,*, Vojo Deretic a,b a Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA b Department of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA article info abstract Article history: Autophagy initiation is strictly dependent on phosphatidylinositol 3-phosphate (PI3P) synthesis. Received 31 December 2009 PI3P production is under tight control of PI3Kinase, hVps34, in complex with Beclin-1. Mammalian Revised 15 February 2010 cells express several PI3P phosphatases that belong to the myotubularin family. Even though some Accepted 16 February 2010 of them have been linked to serious human diseases, their cellular function is largely unknown. Two Available online 24 February 2010 recent studies indicate that PI3P metabolism involved in autophagy initiation is further regulated by Edited by Noboru Mizushima the PI3P phosphatases Jumpy and MTMR3. Additional pools of PI3P, upstream of mTOR and on the endocytic pathway, may modulate autophagy indirectly, suggesting that other PI3P phosphatases might be involved in this process. This review sums up our knowledge on PI3P phosphatases and Keywords: Autophagy discusses the recent progress on their role in autophagy. Myotubularin Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. PI3P Phosphatase Jumpy MTMR14 1. Introduction PI3P phosphatases were one of the likely candidates as it is known that the phosphoinositide, PI3,4,5P3 and its signaling can be down- PI3P synthesis has long been recognized as one of the key regulated by PI3,4,5P3 phosphatase, PTEN.
    [Show full text]
  • Myotubularin-Related Protein (MTMR) 9 Determines the Enzymatic Activity, Substrate Specificity, and Role in Autophagy of MTMR8
    Myotubularin-related protein (MTMR) 9 determines the enzymatic activity, substrate specificity, and role in autophagy of MTMR8 Jun Zoua,1, Chunfen Zhangb,1,2, Jasna Marjanovicc, Marina V. Kisselevab, Philip W. Majerusb,d,2, and Monita P. Wilsonb,2 aDepartment of Pathology and Immunology, bDivision of Hematology, Department of Internal Medicine, and dDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110; and cDivision of Basic and Pharmaceutical Sciences, St. Louis College of Pharmacy, St. Louis, MO 63110 Contributed by Philip W. Majerus, May 1, 2012 (sent for review February 24, 2012) The myotubularins are a large family of inositol polyphosphate myotubularin proteins (16–21). One mechanism that regulates 3-phosphatases that, despite having common substrates, subsume the myotubularins is the formation of heterodimers between unique functions in cells that are disparate. The myotubularin catalytically active and inactive proteins. The interaction between family consists of 16 different proteins, 9 members of which different myotubularin proteins has a significant effect on en- possess catalytic activity, dephosphorylating phosphatidylinositol zymatic activity. For example, the association of myotubularin 3-phosphate [PtdIns(3)P] and phosphatidylinositol 3,5-bisphos- (MTM1) with MTMR12 results in a threefold increase in the 3- phate [PtdIns(3,5)P2] at the D-3 position. Seven members are in- phosphatase activity of MTM1, alters the subcellular localiza- active because they lack the conserved cysteine residue in the tion of MTM1 from the plasma membrane to the cytosol, and CX5R motif required for activity. We studied a subfamily of homol- attenuates the filopodia formation seen with MTM1 overex- ogous myotubularins, including myotubularin-related protein 6 pression (21, 22).
    [Show full text]
  • Phosphatidylinositol-5-Phosphate Activation and Conserved Substrate Specificity of the Myotubularin Phosphatidylinositol 3-Phosphatases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Current Biology, Vol. 13, 504–509, March 18, 2003, 2003 Elsevier Science Ltd. All rights reserved. DOI 10.1016/S0960-9822(03)00132-5 Phosphatidylinositol-5-Phosphate Activation and Conserved Substrate Specificity of the Myotubularin Phosphatidylinositol 3-Phosphatases 1 2 Julia Schaletzky, Stephen K. Dove, displayed activity toward PtdIns3P and PtdIns(3,5)P2, Benjamin Short,1 Oscar Lorenzo,3 but not the other naturally occurring phosphoinositides 3 1 Michael J. Clague, and Francis A. Barr (Figure 1A). The activity toward PtdIns(3,5)P2 adds a 1Department of Cell Biology novel substrate specificity for MTM1 [6] and is consis- Max-Planck-Institute of Biochemistry tent with reports that MTMR2 and MTMR3 use PtdIns3P Am Klopferspitz 18a and PtdIns(3,5)P2 as substrates [10, 11]. Purified MTMR6 Martinsried, 82152 showed the same substrate specificity as MTM1 (Figure Germany 1C), while the active site mutant protein MTMR6C336S 2 School of Biosciences lacked any detectable activity toward either PtdIns3P University of Birmingham or PtdIns(3,5)P2. To confirm that MTM1 hydrolyses The Medical School PtdIns(3,5)P2, we performed an alternate analysis of activ- Birmingham B15 2TT ity described previously for MTMR3 [10]. This assay is 3 Physiological Laboratory carried out in living yeast cells and is useful for establishing University of Liverpool 3-phosphatase activity against PtdIns(3,5)P2, since it Crown Street allows detection of the reaction product PtdIns5P, which Liverpool L69 3BX is not normally detectable in yeast [10, 12, 13].
    [Show full text]
  • Molecular and Genetic Medicine
    Bertazzi et al., J Mol Genet Med 2015, 8:2 Molecular and Genetic Medicine http://dx.doi.org/10.4172/1747-0862.1000116 Review Article Open Access Myotubularin MTM1 Involved in Centronuclear Myopathy and its Roles in Human and Yeast Cells Dimitri L. Bertazzi#, Johan-Owen De Craene# and Sylvie Friant* Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, France #Authors contributed equally to this work. *Corresponding author: Friant S, Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, 67084 Strasbourg, France, E-mail: [email protected] Received date: April 17, 2014; Accepted date: July 21, 2014; Published date: July 28, 2014 Copyright: © 2014 Bertazzi DL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Mutations in the MTM1 gene, encoding the phosphoinositide phosphatase myotubularin, are responsible for the X-linked centronuclear myopathy (XLCNM) or X-linked myotubular myopathy (XLMTM). The MTM1 gene was first identified in 1996 and its function as a PtdIns3P and PtdIns(,5)P2 phosphatase was discovered in 2000. In recent years, very important progress has been made to set up good models to study MTM1 and the XLCNM disease such as knockout or knockin mice, the Labrador Retriever dog, the zebrafish and the yeast Saccharomyces cerevisiae. These helped to better understand the cellular function of MTM1 and of its four conserved domains: PH-GRAM (Pleckstrin Homology-Glucosyltransferase, Rab-like GTPase Activator and Myotubularin), RID (Rac1-Induced recruitment Domain), PTP/DSP (Protein Tyrosine Phosphatase/Dual-Specificity Phosphatase) and SID (SET-protein Interaction Domain).
    [Show full text]
  • Phosphatome Rnai Screen Identifies Eya1 As a Positive Regulator of Hedgehog Signal Transduction
    Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Eisner, Adriana. 2013. Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11181213 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction A dissertation presented by Adriana Eisner to The Division of Medical Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Neurobiology Harvard University Cambridge, Massachusetts June 2013 © 2013 Adriana Eisner All rights reserved. Dissertation Advisor: Dr. Rosalind Segal Adriana Eisner Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction Abstract The Hedgehog (Hh) signaling pathway is vital for vertebrate embryogenesis and aberrant activation of the pathway can cause tumorigenesis in humans. In this study, we used a phosphatome RNAi screen for regulators of Hh signaling to identify a member of the Eyes Absent protein family, Eya1, as a positive regulator of Hh signal transduction. Eya1 is both a phosphatase and transcriptional regulator. Eya family members have been implicated in tumor biology, and Eya1 is highly expressed in a particular subtype of medulloblastoma (MB).
    [Show full text]
  • Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke
    Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke University Date: May 1 st 2009 Approved: ___________________________ Dr. Patrick J. Casey, Supervisor ___________________________ Dr. Perry J. Blackshear ___________________________ Dr. Anthony R. Means ___________________________ Dr. Christopher B. Newgard ___________________________ Dr. John D. York Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2009 ABSTRACT Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke University Date: May 1 st 2009 Approved: ___________________________ Dr. Patrick J. Casey, Supervisor ___________________________ Dr. Perry J. Blackshear ___________________________ Dr. Anthony R. Means ___________________________ Dr. Christopher B. Newgard ___________________________ Dr. John D. York An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2009 Copyright by Dahlia Doughty Shenton 2009 Abstract The dual specificity protein tyrosine phosphatases comprise the largest and most diverse group of protein tyrosine phosphatases and play integral roles in the regulation of cell signaling events. The dual specificity protein tyrosine phosphatases impact multiple
    [Show full text]
  • Mir-506-3P Suppresses the Proliferation of Ovarian Cancer Cells by Negatively Regulating the Expression of MTMR6
    J Biosci (2019) 44:126 Ó Indian Academy of Sciences DOI: 10.1007/s12038-019-9952-9 (0123456789().,-volV)(0123456789().,-volV) MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6 YUAN WANG,XIA LEI,CHENGYING GAO,YANXIA XUE,XIAOLIN LI,HAIYING WANG and YAN FENG* Department of Gynaecology, Yan’an University Affiliated Hospital, Yanan, Shaanxi Province, China *Corresponding author (Email, [email protected]) MS received 10 February 2019; accepted 26 July 2019; published online 22 October 2019 MicroRNAs have been reported to play a crucial role in ovarian cancer (OC) as the most lethal malignancy of the women. Here, we found miR-506-3p was significantly down-regulated in OC tissues compared with corresponding adjacent non- tumor tissues. Ectopic miR-506-3p expression inhibited OC cell growth and proliferation using MTT and colony formation assay. Additionally, flow cytometry analysis showed that the overexpression of miR-506-3p induced cell cycle G0/G1 phase arrest and cell apoptosis in OC cells. A luciferase reporter assay confirmed that the myotubularin-related protein 6 (MTMR6) was the target of miR-506-3p. The expression of MTMR6 was increased in OC tissues compared with adjacent tissues using immunohistochemistry. Elevated MTMR6 protein levels were confirmed in OC cells lines compared with immortalized fallopian tube epithelial cell line FTE187 using western blotting. In addition, knockdown of MTMR6 imitated the effects of miR-506-3p on cell proliferation, cell cycle progression and apoptosis in OC cells. Furthermore, rescue experiments using MTMR6 overexpression further verified that MTMR6 was a functional target of miR-506-3p.
    [Show full text]
  • Expression Profile of Tyrosine Phosphatases in HER2 Breast
    Cellular Oncology 32 (2010) 361–372 361 DOI 10.3233/CLO-2010-0520 IOS Press Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors Maria Antonietta Lucci a, Rosaria Orlandi b, Tiziana Triulzi b, Elda Tagliabue b, Andrea Balsari c and Emma Villa-Moruzzi a,∗ a Department of Experimental Pathology, University of Pisa, Pisa, Italy b Molecular Biology Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy c Department of Human Morphology and Biomedical Sciences, University of Milan, Milan, Italy Abstract. Background: HER2-overexpression promotes malignancy by modulating signalling molecules, which include PTPs/DSPs (protein tyrosine and dual-specificity phosphatases). Our aim was to identify PTPs/DSPs displaying HER2-associated expression alterations. Methods: HER2 activity was modulated in MDA-MB-453 cells and PTPs/DSPs expression was analysed with a DNA oligoar- ray, by RT-PCR and immunoblotting. Two public breast tumor datasets were analysed to identify PTPs/DSPs differentially ex- pressed in HER2-positive tumors. Results: In cells (1) HER2-inhibition up-regulated 4 PTPs (PTPRA, PTPRK, PTPN11, PTPN18) and 11 DSPs (7 MKPs [MAP Kinase Phosphatases], 2 PTP4, 2 MTMRs [Myotubularin related phosphatases]) and down-regulated 7 DSPs (2 MKPs, 2 MTMRs, CDKN3, PTEN, CDC25C); (2) HER2-activation with EGF affected 10 DSPs (5 MKPs, 2 MTMRs, PTP4A1, CDKN3, CDC25B) and PTPN13; 8 DSPs were found in both groups. Furthermore, 7 PTPs/DSPs displayed also altered protein level. Analysis of 2 breast cancer datasets identified 6 differentially expressed DSPs: DUSP6, strongly up-regulated in both datasets; DUSP10 and CDC25B, up-regulated; PTP4A2, CDC14A and MTMR11 down-regulated in one dataset.
    [Show full text]
  • Phosphatases Page 1
    Phosphatases esiRNA ID Gene Name Gene Description Ensembl ID HU-05948-1 ACP1 acid phosphatase 1, soluble ENSG00000143727 HU-01870-1 ACP2 acid phosphatase 2, lysosomal ENSG00000134575 HU-05292-1 ACP5 acid phosphatase 5, tartrate resistant ENSG00000102575 HU-02655-1 ACP6 acid phosphatase 6, lysophosphatidic ENSG00000162836 HU-13465-1 ACPL2 acid phosphatase-like 2 ENSG00000155893 HU-06716-1 ACPP acid phosphatase, prostate ENSG00000014257 HU-15218-1 ACPT acid phosphatase, testicular ENSG00000142513 HU-09496-1 ACYP1 acylphosphatase 1, erythrocyte (common) type ENSG00000119640 HU-04746-1 ALPL alkaline phosphatase, liver ENSG00000162551 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPPL2 alkaline phosphatase, placental-like 2 ENSG00000163286 HU-07767-1 BPGM 2,3-bisphosphoglycerate mutase ENSG00000172331 HU-06476-1 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 ENSG00000162813 HU-09086-1 CANT1 calcium activated nucleotidase 1 ENSG00000171302 HU-03115-1 CCDC155 coiled-coil domain containing 155 ENSG00000161609 HU-09022-1 CDC14A CDC14 cell division cycle 14 homolog A (S. cerevisiae) ENSG00000079335 HU-11533-1 CDC14B CDC14 cell division cycle 14 homolog B (S. cerevisiae) ENSG00000081377 HU-06323-1 CDC25A cell division cycle 25 homolog A (S. pombe) ENSG00000164045 HU-07288-1 CDC25B cell division cycle 25 homolog B (S. pombe) ENSG00000101224 HU-06033-1 CDKN3 cyclin-dependent kinase inhibitor 3 ENSG00000100526 HU-02274-1 CTDSP1 CTD (carboxy-terminal domain,
    [Show full text]
  • Protein Tyrosine Phosphatase-PEST (PTP-PEST) Mediates Hypoxia
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.15.152942; this version posted June 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Protein tyrosine phosphatase-PEST (PTP-PEST) mediates hypoxia- 2 induced endothelial autophagy and angiogenesis through AMPK 3 activation. 4 Shivam Chandel1, Amrutha Manikandan1, Nikunj Mehta1, Abel Arul Nathan1, Rakesh 5 Kumar Tiwari1, Samar Bhallabha Mohapatra1, Mahesh Chandran2, Abdul Jaleel2, 6 Narayanan Manoj1 and Madhulika Dixit1. 7 8 1. Department of Biotechnology, 9 Bhupat and Jyoti Mehta School of Biosciences, 10 Indian Institute of Technology Madras (IIT Madras), 11 Chennai, INDIA, 600036 12 2. Rajiv Gandhi Centre for Biotechnology (RGCB), 13 Thyacaud Post, Thiruvananthpuram, 14 Kerala, INDIA, 695014 15 16 Corresponding Author: 17 Madhulika Dixit 18 Department of Biotechnology, 19 Bhupat and Jyoti Mehta School of Biosciences, 20 Indian Institute of Technology Madras 21 Chennai, INDIA, 600036 22 23 Phone: +91-44-22574131 24 E-mail: [email protected] 25 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.15.152942; this version posted June 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 26 Abstract: 27 Global and endothelial loss of PTP-PEST is associated with impaired cardiovascular 28 development and embryonic lethality. Although hypoxia is implicated in vascular 29 morphogenesis and remodelling, its effect on PTP-PEST remains unexplored. Here we 30 report that hypoxia (1% oxygen)increases protein levels and catalytic activity of PTP- 31 PEST in primary endothelial cells.
    [Show full text]
  • Lipid Phosphatases Identified by Screening a Mouse Phosphatase
    Lipid phosphatases identified by screening a mouse PNAS PLUS phosphatase shRNA library regulate T-cell differentiation and Protein kinase B AKT signaling Liying Guoa, Craig Martensb, Daniel Brunob, Stephen F. Porcellab, Hidehiro Yamanea, Stephane M. Caucheteuxa, Jinfang Zhuc, and William E. Paula,1 aCytokine Biology Unit, cMolecular and Cellular Immunoregulation Unit, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and bGenomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840 Contributed by William E. Paul, March 27, 2013 (sent for review December 18, 2012) Screening a complete mouse phosphatase lentiviral shRNA library production (10, 11). Conversely, constitutive expression of active using high-throughput sequencing revealed several phosphatases AKT leads to increased proliferation and enhanced Th1/Th2 cy- that regulate CD4 T-cell differentiation. We concentrated on two lipid tokine production (12). phosphatases, the myotubularin-related protein (MTMR)9 and -7. The amount of PI[3,4,5]P3 and the level of AKT activation are Silencing MTMR9 by shRNA or siRNA resulted in enhanced T-helper tightly controlled by several mechanisms, including breakdown of (Th)1 differentiation and increased Th1 protein kinase B (PKB)/AKT PI[3,4,5]P3, down-regulation of the amount and activity of PI3K, phosphorylation while silencing MTMR7 caused increased Th2 and and the dephosphorylation of AKT (13). PTEN is a major negative Th17 differentiation and increased AKT phosphorylation in these regulator of PI[3,4,5]P3. It removes the 3-phosphate from the cells.
    [Show full text]
  • Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared Amongst Δγ T, Innate Lymphoid, and Th Cells
    Downloaded from http://www.jimmunol.org/ by guest on October 2, 2021 δγ is online at: average * The Journal of Immunology , 10 of which you can access for free at: 2016; 197:1460-1470; Prepublished online 6 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600643 http://www.jimmunol.org/content/197/4/1460 Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared amongst T, Innate Lymphoid, and Th Cells You Jeong Lee, Gabriel J. Starrett, Seungeun Thera Lee, Rendong Yang, Christine M. Henzler, Stephen C. Jameson and Kristin A. Hogquist J Immunol cites 41 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2016/07/06/jimmunol.160064 3.DCSupplemental This article http://www.jimmunol.org/content/197/4/1460.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 2, 2021. The Journal of Immunology Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared amongst gd T, Innate Lymphoid, and Th Cells You Jeong Lee,* Gabriel J.
    [Show full text]